Phylogeography and transmission of Mycobacterium tuberculosis spanning prisons and surrounding communities in Paraguay.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
19 01 2023
Historique:
received: 20 08 2022
accepted: 04 01 2023
entrez: 19 1 2023
pubmed: 20 1 2023
medline: 24 1 2023
Statut: epublish

Résumé

Recent rises in incident tuberculosis (TB) cases in Paraguay and the increasing concentration of TB within prisons highlight the urgency of targeting strategies to interrupt transmission and prevent new infections. However, whether specific cities or carceral institutions play a disproportionate role in transmission remains unknown. We conducted prospective genomic surveillance, sequencing 471 Mycobacterium tuberculosis complex genomes, from inside and outside prisons in Paraguay's two largest urban areas, Asunción and Ciudad del Este, from 2016 to 2021. We found genomic evidence of frequent recent transmission within prisons and transmission linkages spanning prisons and surrounding populations. We identified a signal of frequent M. tuberculosis spread between urban areas and marked recent population size expansion of the three largest genomic transmission clusters. Together, our findings highlight the urgency of strengthening TB control programs to reduce transmission risk within prisons in Paraguay, where incidence was 70 times that outside prisons in 2021.

Identifiants

pubmed: 36658111
doi: 10.1038/s41467-023-35813-9
pii: 10.1038/s41467-023-35813-9
pmc: PMC9849832
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

303

Subventions

Organisme : NIAID NIH HHS
ID : K01 AI173385
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI130058
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI149620
Pays : United States

Informations de copyright

© 2023. The Author(s).

Références

Bull World Health Organ. 1974;51(1):71-82
pubmed: 4218139
Microb Genom. 2022 Jul;8(7):
pubmed: 35787782
Genome Med. 2019 Jun 24;11(1):41
pubmed: 31234910
Lancet Respir Med. 2014 Apr;2(4):285-292
pubmed: 24717625
Nat Med. 2021 Jul;27(7):1171-1177
pubmed: 34031604
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Nat Commun. 2021 Dec 15;12(1):7312
pubmed: 34911948
Lancet Infect Dis. 2013 Feb;13(2):137-46
pubmed: 23158499
Mol Ecol Resour. 2017 Jul;17(4):721-729
pubmed: 27768245
Lancet Reg Health Am. 2022 May;9:
pubmed: 35647574
J Clin Microbiol. 2003 Sep;41(9):4471-4
pubmed: 12958298
Syst Biol. 2003 Apr;52(2):131-58
pubmed: 12746144
Elife. 2015 Mar 03;4:
pubmed: 25732036
PLoS Comput Biol. 2019 Apr 8;15(4):e1006650
pubmed: 30958812
Science. 1996 Jun 14;272(5268):1641-3
pubmed: 8658136
Sci Rep. 2017 Mar 28;7:45326
pubmed: 28349973
Genome Biol. 2004;5(2):R12
pubmed: 14759262
Lancet. 2021 Apr 24;397(10284):1591-1596
pubmed: 33838724
Microb Genom. 2016 Apr 29;2(4):e000056
pubmed: 28348851
Bioinformatics. 2019 Feb 1;35(3):526-528
pubmed: 30016406
PLoS Med. 2020 Jan 21;17(1):e1003023
pubmed: 31961857
Curr Protoc Bioinformatics. 2020 Mar;69(1):e96
pubmed: 32162851
Gigascience. 2021 Feb 16;10(2):
pubmed: 33590861
Bioinformatics. 2012 Feb 15;28(4):593-4
pubmed: 22199392
Lancet Public Health. 2021 May;6(5):e300-e308
pubmed: 33765455
Clin Microbiol Infect. 2013 Oct;19(10):889-901
pubmed: 23731470
Front Microbiol. 2018 Nov 27;9:2820
pubmed: 30538680
Int J Tuberc Lung Dis. 2013 Jun;17(6):782-6
pubmed: 23676162
Genome Biol. 2014 Mar 03;15(3):R46
pubmed: 24580807
J Infect Dis. 2017 Nov 3;216(suppl_6):S629-S635
pubmed: 29112747
Nat Genet. 2016 Dec;48(12):1535-1543
pubmed: 27798628
Lancet Microbe. 2021 Mar;2(3):e96-e104
pubmed: 33912853
Mol Biol Evol. 2018 Dec 1;35(12):3041-3043
pubmed: 30351396
Mol Biol Evol. 2020 May 1;37(5):1530-1534
pubmed: 32011700
BMC Microbiol. 2007 Aug 08;7:75
pubmed: 17686181
PLoS Med. 2020 Jan 21;17(1):e1003008
pubmed: 31961877
Nat Genet. 2018 Feb;50(2):307-316
pubmed: 29358649
Mol Biol Evol. 2018 Feb 1;35(2):518-522
pubmed: 29077904
Genes (Basel). 2019 Jan 16;10(1):
pubmed: 30654542
Curr Protoc Bioinformatics. 2013;43:11.10.1-11.10.33
pubmed: 25431634
Mol Biol Evol. 2005 May;22(5):1185-92
pubmed: 15703244
Sci Adv. 2018 Oct 17;4(10):eaat5869
pubmed: 30345355
Trop Med Int Health. 2020 Sep;25(9):1065-1078
pubmed: 32506718
Nat Methods. 2017 Jun;14(6):587-589
pubmed: 28481363
Genome Med. 2015 May 27;7(1):51
pubmed: 26019726
Microb Genom. 2020 Aug;6(8):
pubmed: 32735210
PLoS Comput Biol. 2018 Feb 5;14(2):e1005958
pubmed: 29401456
PLoS Med. 2022 Feb 22;19(2):e1003933
pubmed: 35192619
Bioinformatics. 2015 Jun 15;31(12):2032-4
pubmed: 25697820
Sci Rep. 2020 Dec 4;10(1):21247
pubmed: 33277515
PLoS Pathog. 2019 Sep 12;15(9):e1008067
pubmed: 31513651

Auteurs

Gladys Estigarribia Sanabria (GE)

Instituto Regional de Investigación en Salud, Caaguazú, Paraguay. lalyestigarr@gmail.com.

Guillermo Sequera (G)

Instituto de Salud Global de Barcelona (ISGLOBAL), Barcelona, Spain.
Programa Nacional de Control de la Tuberculosis, Ministerio de Salud Pública y Bienestar Social (MSPyBS), Asunción, Paraguay.

Sarita Aguirre (S)

Programa Nacional de Control de la Tuberculosis, Ministerio de Salud Pública y Bienestar Social (MSPyBS), Asunción, Paraguay.

Julieta Méndez (J)

Instituto Regional de Investigación en Salud, Caaguazú, Paraguay.

Paulo César Pereira Dos Santos (PCP)

Postgraduate Program in Infectious and Parasitic Diseases, Federal University of Mato Grosso do Sul, Mato Grosso do Sul, Brazil.

Natalie Weiler Gustafson (NW)

Laboratorio Central de Salud Pública (LCSP), Ministerio de Salud Publica y Bienestar Social (MSPyBS), Asunción, Paraguay.

Margarita Godoy (M)

Laboratorio Central de Salud Pública (LCSP), Ministerio de Salud Publica y Bienestar Social (MSPyBS), Asunción, Paraguay.

Analía Ortiz (A)

Instituto Regional de Investigación en Salud, Caaguazú, Paraguay.

Cynthia Cespedes (C)

Programa Nacional de Control de la Tuberculosis, Ministerio de Salud Pública y Bienestar Social (MSPyBS), Asunción, Paraguay.

Gloria Martínez (G)

Instituto Regional de Investigación en Salud, Caaguazú, Paraguay.

Alberto L García-Basteiro (AL)

Instituto de Salud Global de Barcelona (ISGLOBAL), Barcelona, Spain.
Centro de Investigação em Saude de Manhiça (CISM), Maputo, Mozambique.
Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Barcelona, Spain.

Jason R Andrews (JR)

Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA.

Julio Croda (J)

Federal University of Mato Grosso do Sul - UFMS, Campo Grande, MS, Brazil.
Oswaldo Cruz Foundation Mato Grosso do Sul, Mato Grosso do Sul, Brazil.
Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, USA.

Katharine S Walter (KS)

Division of Epidemiology, University of Utah, Salt Lake City, UT, 84105, USA. katharine.walter@hsc.utah.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH